http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9421249-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7513ea39acbdb207dc3a3a6acd5c17ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6f4e6650e7951720495516b867e754f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-285 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-36 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-285 |
| filingDate | 1993-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8e303931ff172a4d1834f0e5e3d6887 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d14c6bc2567cb35dffc1c034c12334b3 |
| publicationDate | 1994-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9421249-A1 |
| titleOfInvention | Arsenic medicaments for the treatment of the chronic asthenia syndrome |
| abstract | The object of my invention is to provide a very safe and active drug against the new infectious disease called Chronic Asthenia Syndrome. This illness is characterized by chronic debilitation and anorexia, mild fever, myalgia, momentary paresis, generalized muscle weakness, tendency to sleeping, losing weight and resistance to perform the normal activity. Laboratory findings are represented by high levels of Creatine Phosphokinase (CPK) and Creatinine, Magnesium deficiency, decreased haematocrit and Mean Corpuscular Volume (MCV), hypogammaglobulinaemia, eosinophilia and Monocytosis. The intravenous injection of 0.1 milliliter of Caparsolate or Filaramide per Kilogram of body weight made twice, at a distance of 24 hours, can resolve the symptoms and the aetiology of the infectious disease called Chronic Asthenia Syndrome. The Arsenic, and all his organic and inorganic compounds, works as very good drugs against Chronic Asthenia Syndrome. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8394422-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8497300-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0911031-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0911031-A3 |
| priorityDate | 1993-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.